Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NOVN crawled time : 13:00 save search
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -63.13%
H: 2.09%
C: -20.11%
LGND | $70.87 1.4% 1.38% 150K
|
Health Technology
|
| O: 0.94%
H: 1.74%
C: 0.39%
sb206 agreement
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published: 2023-06-05 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 2.65%
H: 4.31%
C: -0.86%
update meeting
Novan to Report Full Year 2022 Financial Results on March 30, 2023
Published: 2023-03-23 (Crawled : 13:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -8.0%
report year financial results
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
Published: 2022-12-02 (Crawled : 13:00) - novan.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 10.53%
H: 12.7%
C: -7.94%
HTBK | $8.35 0.6% 0.6% 310K
|
Finance
|
| O: -0.84%
H: 0.78%
C: 0.0%
agreement
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-21 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.97%
H: 6.7%
C: 3.85%
unique therapeutics
EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-21 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.97%
H: 6.7%
C: 3.85%
conference therapeutics psoriasis
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
Published: 2022-10-14 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.42%
H: 0.0%
C: -4.13%
conference presentation
Novan Satisfies $16.5 Million Outstanding Promissory Note
Published: 2022-07-19 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 11.52%
H: 0.0%
C: -4.8%
Novan Announces Approximately $15.0 Million Registered Direct Offering Priced At-the-Market
Published: 2022-06-09 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -10.21%
H: 6.27%
C: 5.1%
offering
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 1.44%
H: 5.26%
C: 2.7%
Novan Appoints Brian M. Johnson as Chief Commercial Officer and Receives Conditional FDA Acceptance of Proposed Brand Name KINSOLUS™ for SB206 in Molluscum Contagiosum
Published: 2021-11-02 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.7%
H: 1.0%
C: -0.14%
molluscum fda fda acceptance
Novan Announces Strategic Priorities and Outlines Key Milestones
Published: 2021-09-09 (Crawled : 13:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M
|
Health Services
|
| O: 0.17%
H: 0.91%
C: -0.21%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -6.59%
H: 0.0%
C: -4.42%
milestone
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-07 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -0.2%
H: 3.94%
C: -1.11%
conference
Novan Appoints Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer
Published: 2021-08-24 (Crawled : 13:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.38%
H: 0.62%
C: -2.73%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.6%
H: 0.47%
C: -1.29%
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 2.16%
H: 2.65%
C: 2.12%
Novan Announces Positive Preclinical Data in SB019 COVID-19 Anti-Viral Therapy Program
Published: 2021-06-10 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 3.84%
H: 8.15%
C: -1.74%
covid positive therapy antiviral preclinical covid-19 pre-clinical
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
Published: 2021-04-22 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 11.8%
H: 8.87%
C: 3.97%
Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
Published: 2021-02-25 (Crawled : 13:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: -2.84%
H: 2.34%
C: -6.43%
financial results results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.